CD8A and neoplasm: The novel immune checkpoint TIGIT expressed on NK cells, activated CD8+ T cells, effector CD8+ T cells and regulatory T cells (Tregs), and suppressed the anti-tumor immune response by interacting with PVR [19, 20, 34].